Medical Devices & Supplies - Diversified Stocks Q3 In Review: CooperCompanies (NASDAQ:COO) Vs Peers
AI Sentiment
Positive
6/10
as of 01-05-2026 3:42pm EST
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
| Founded: | 1980 | Country: | United States |
| Employees: | N/A | City: | SAN RAMON |
| Market Cap: | 16.1B | IPO Year: | N/A |
| Target Price: | $88.55 | AVG Volume (30 days): | 3.0M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.87 | EPS Growth: | -4.59 |
| 52 Week Low/High: | $61.77 - $100.24 | Next Earning Date: | 12-04-2025 |
| Revenue: | $4,092,400,000 | Revenue Growth: | 5.06% |
| Revenue Growth (this year): | 6.56% | Revenue Growth (next year): | 5.32% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director
Avg Cost/Share
$84.06
Shares
1,784
Total Value
$149,963.04
Owned After
9,445
SEC Form 4
Director
Avg Cost/Share
$82.13
Shares
1,000
Total Value
$82,130.00
Owned After
11,141
SEC Form 4
Director
Avg Cost/Share
$82.50
Shares
2,000
Total Value
$165,000.00
Owned After
7,777
SEC Form 4
President & CEO
Avg Cost/Share
$80.80
Shares
10,000
Total Value
$808,000.00
Owned After
236,151
SEC Form 4
President, CSI
Avg Cost/Share
$80.75
Shares
1,230
Total Value
$99,322.50
Owned After
39,052
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Lucchese Cynthia L | COO | Director | Dec 22, 2025 | Buy | $84.06 | 1,784 | $149,963.04 | 9,445 | |
| Rivas Maria | COO | Director | Dec 18, 2025 | Buy | $82.13 | 1,000 | $82,130.00 | 11,141 | |
| Kurzius Lawrence Erik | COO | Director | Dec 17, 2025 | Buy | $82.50 | 2,000 | $165,000.00 | 7,777 | |
| White Albert G III | COO | President & CEO | Dec 16, 2025 | Buy | $80.80 | 10,000 | $808,000.00 | 236,151 | |
| Sheffield Holly R | COO | President, CSI | Dec 16, 2025 | Buy | $80.75 | 1,230 | $99,322.50 | 39,052 |
COO Breaking Stock News: Dive into COO Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
6/10
AI Sentiment
Negative
3/10
AI Sentiment
Neutral
4/10
See how COO stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "COO The Cooper Companies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.